老花眼矯正植入器材市場規模、佔有率及成長分析：按類型、器材、材料、年齡層、最終用戶和地區分類－2026-2033年產業預測

2024 年全球老花眼矯正植入市場價值為 99 億美元，預計到 2025 年將成長至 113.9 億美元，到 2033 年將成長至 351 億美元，在預測期（2026-2033 年）內複合年成長率為 15.1%。

老花眼矯正植入式設備市場的主要驅動力是人口老化。隨著預期壽命的延長，老年人對擺脫眼鏡的需求日益成長。該市場涵蓋各種外科植入，例如人工水晶體和角膜嵌體，這些植入物對於改善近距離和中距離視力至關重要，並能夠顯著提高患者的整體生產力和生活品質。隨著治療方式從依賴眼鏡轉向手術干預，水晶體設計和手術技術的進步至關重要。技術創新正在提升手術過程中的光學性能和引導效果，從而提高患者滿意度，並促使醫療專業人員推薦高階設備。此外，人工智慧的整合提高了診斷準確性，實現了個人化的手術方案製定和最佳化的治療效果，進一步促進了全球市場的發展和成長，尤其是在白內障病例不斷增加的新興國家。

推動全球老花眼矯正植入市場發展的因素

患者對擺脫眼鏡的渴望日益成長，顯著影響了老花眼矯正手術中人工水晶體的應用。這一趨勢迫使醫療機構引入能夠有效改善近距離和遠視的手術治療方法。隨著患者越來越重視便利性和生活品質的提升，對這些解決方案的需求不斷成長，促使醫療機構拓展服務範圍，並投資必要的培訓和設備。滿意的患者常常共用他們的積極體驗，這不僅促進了人工晶體的普及，也鼓勵外科醫生在實踐中採用這些創新設備，從而透過加強臨床整合和以患者主導中心的服務，推動永續成長。

全球植入式老花眼矯正設備市場面臨的限制因素

全球老花眼矯正植入式設備市場成長受到報銷和保險覆蓋範圍差異等問題的限制。這些因素給患者帶來沉重的經濟負擔，也為考慮投資專用設備和必要培訓的醫療機構帶來不確定性。當保險公司將老花眼矯正歸類為「擇期手術」時，臨床醫生難以獲得穩定的報銷，患者則面臨高額的自付費用，從而阻礙了該療法的普及。這種情況阻礙了醫療系統對這些治療方法的廣泛應用，最終導致轉診減少和治療選擇受限。因此，這也影響了製造商和服務供應商拓展產品線的意願。

全球老花眼矯正植入市場趨勢

全球老花眼矯正植入物市場正呈現出向個人化植入解決方案發展的顯著趨勢。製造商和臨床醫生正優先考慮可客製化的設計和可調節的光學系統，以滿足老花眼患者獨特的視覺需求和生活方式偏好。這項轉變的特點是模組化組件的整合，從而實現手術調整和使用患者特異性生物相容性材料，進而提升治療效果的感知度並提高患者滿意度。隨著對個人化治療方案的日益重視，設備開發商、眼科醫師和病患權益組織之間的合作日益加強，推動了創新和知情決策。這有助於增強品牌忠誠度，並在競爭激烈的市場環境中維持臨床信譽。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球老花眼矯正植入設備市場規模：依類型分類

• 角膜嵌體
• 鞏膜植入

全球老花眼矯正植入設備市場規模：依設備類型分類

• 單焦點植入
• 多焦點植入
• 環形植入

全球老花眼矯正植入設備市場規模：依材料分類。

• 矽酮
• 丙烯酸纖維

全球老花眼矯正植入設備市場規模：依年齡層分類

• 40-50歲
• 50-65歲
• 65歲或以上

全球老花眼矯正植入設備市場規模：依最終用戶分類

• 醫院和診所
• 門診手術中心

全球老花眼矯正植入設備市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要企業2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要企業的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要企業簡介

• AcuFocus, Inc.
• Alcon Vision LLC
• ReVision Optics
• LifePoint Health
• Bausch+Lomb
• Vortecia
• Allergan, a subsidiary of AbbVie
• Eyepoint Pharmaceuticals
• Croma Pharma GmbH
• Vision Solutions, Inc.
• Presbyopia Therapy, Inc.
• Eyetec, Inc.
• Shringrix Technologies
• Ocular Dynamics
• Dextina Health
• Solos Endoscopy
• Presbia PLC
• 4D Vision
• Insight Vision
• Adaptica Srl

結論與建議

Global Implantable Presbyopia Correction Devices Market size was valued at USD 9.9 Billion in 2024 and is poised to grow from USD 11.39 Billion in 2025 to USD 35.1 Billion by 2033, growing at a CAGR of 15.1% during the forecast period (2026-2033).

The implantable presbyopia correction devices market is primarily driven by an aging demographic, as increased life expectancy amplifies the demand for independence from spectacles among older adults. This market includes various surgical implants, such as intraocular lenses and corneal inlays, critical for enhancing near and intermediate vision, which significantly impacts overall productivity and quality of life. As the sector shifts from reliance on spectacles to surgical interventions, technological advancements in lens design and surgical techniques become essential. Innovations foster improved optics and guidance during procedures, raising patient satisfaction and encouraging clinician recommendations for premium devices. Additionally, the integration of AI enhances diagnostic accuracy, customizes surgical planning, and optimizes outcomes, further fueling engagement and growth globally, particularly in emerging economies with increasing cataract cases.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Implantable Presbyopia Correction Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Implantable Presbyopia Correction Devices Market Segments Analysis

Global implantable presbyopia correction devices market is segmented by type, device type, material, age group, end user and region. Based on type, the market is segmented into Corneal Inlays and Scleral Implants. Based on device type, the market is segmented into Monofocal Implants, Multifocal Implants and Toric Implants. Based on material, the market is segmented into Silicone and Acrylic. Based on age group, the market is segmented into Age 40-50, Age 50-65 and Age above 65. Based on end user, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Implantable Presbyopia Correction Devices Market

The growing desire among patients for independence from spectacles is significantly influencing the adoption of implantable presbyopia correction devices. This trend prompts healthcare providers to introduce surgical alternatives that effectively enhance both near and distance vision. As patients increasingly focus on convenience and improving their overall quality of life, the demand for these solutions propels providers to broaden their service offerings and invest in necessary training and equipment. Satisfied patients often share their positive experiences, which not only boosts acceptance but also encourages surgeons to adopt these innovative devices in their practices, fostering a sustainable growth trajectory through enhanced clinical integration and consumer-driven services.

Restraints in the Global Implantable Presbyopia Correction Devices Market

The growth of the global implantable presbyopia correction devices market is hindered by challenges related to reimbursement and varying insurance coverage. These factors impose a heavy financial burden on patients and create uncertainty for healthcare providers who are contemplating investments in specialized devices and the necessary training. When insurance companies categorize presbyopia correction as an elective procedure, it hampers adoption rates, as clinicians struggle to secure consistent compensation while patients are faced with high out-of-pocket costs. This situation discourages health systems from widely implementing these treatments, ultimately decreasing referral volumes and limiting access to options, which in turn affects manufacturers' and service providers' willingness to diversify their offerings.

Market Trends of the Global Implantable Presbyopia Correction Devices Market

The Global Implantable Presbyopia Correction Devices market is witnessing a significant trend toward personalized implant solutions. Manufacturers and clinicians are prioritizing customizable designs and adjustable optics tailored to the unique visual requirements and lifestyle preferences of presbyopic individuals. This shift is characterized by the integration of modular components, allowing for surgeon-controlled adjustments, and the use of patient-specific biocompatible materials to improve perceived outcomes and enhance patient satisfaction. The growing emphasis on individualized treatment pathways fosters collaboration among device developers, ophthalmic surgeons, and patient advocates, driving innovation and informed decision-making, ultimately strengthening brand loyalty and maintaining clinical credibility in a competitive landscape.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Implantable Presbyopia Correction Devices Market Size by Type & CAGR (2026-2033)

• Market Overview
• Corneal Inlays
• Scleral Implants

Global Implantable Presbyopia Correction Devices Market Size by Device Type & CAGR (2026-2033)

• Market Overview
• Monofocal Implants
• Multifocal Implants
• Toric Implants

Global Implantable Presbyopia Correction Devices Market Size by Material & CAGR (2026-2033)

• Market Overview
• Silicone
• Acrylic

Global Implantable Presbyopia Correction Devices Market Size by Age Group & CAGR (2026-2033)

• Market Overview
• Age 40-50
• Age 50-65
• Age above 65

Global Implantable Presbyopia Correction Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Ambulatory Surgical Centers

Global Implantable Presbyopia Correction Devices Market Size & CAGR (2026-2033)

• North America (Type, Device Type, Material, Age Group, End User)
  • US
  • Canada
• Europe (Type, Device Type, Material, Age Group, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Device Type, Material, Age Group, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Device Type, Material, Age Group, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Device Type, Material, Age Group, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• AcuFocus, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon Vision LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReVision Optics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifePoint Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch + Lomb
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vortecia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan, a subsidiary of AbbVie
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eyepoint Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Croma Pharma GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vision Solutions, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Presbyopia Therapy, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eyetec, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shringrix Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ocular Dynamics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dextina Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solos Endoscopy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Presbia PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 4D Vision
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insight Vision
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adaptica Srl
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations